These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33818825)

  • 1. Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands).
    Duarte DJ; Niebaum G; Lämmchen V; van Heijnsbergen E; Oldenkamp R; Hernández-Leal L; Schmitt H; Ragas AMJ; Klasmeier J
    Environ Toxicol Chem; 2022 Mar; 41(3):648-662. PubMed ID: 33818825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human health risk assessment of pharmaceuticals in the European Vecht River.
    Duarte DJ; Oldenkamp R; Ragas AMJ
    Integr Environ Assess Manag; 2022 Nov; 18(6):1639-1654. PubMed ID: 35112470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Risk Assessment of Pharmaceuticals in the Environment: Current Practice and Future Priorities.
    Oldenkamp R; Hamers T; Wilkinson J; Slootweg J; Posthuma L
    Environ Toxicol Chem; 2024 Mar; 43(3):611-622. PubMed ID: 36484757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Potential Ecotoxicological Effects of Pharmaceuticals in the World's Rivers.
    Bouzas-Monroy A; Wilkinson JL; Melling M; Boxall ABA
    Environ Toxicol Chem; 2022 Aug; 41(8):2008-2020. PubMed ID: 35730333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Pollution of the English National Parks.
    Boxall ABA; Collins R; Wilkinson JL; Swan C; Bouzas-Monroy A; Jones J; Winter E; Leach J; Juta U; Deacon A; Townsend I; Kerr P; Paget R; Rogers M; Greaves D; Turner D; Pearson C
    Environ Toxicol Chem; 2024 Nov; 43(11):2422-2435. PubMed ID: 39138896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of water quality guidelines for priority pharmaceuticals.
    Kumar A; Batley GE; Nidumolu B; Hutchinson TH
    Environ Toxicol Chem; 2016 Jul; 35(7):1815-24. PubMed ID: 26660719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment.
    Liu J; Dan X; Lu G; Shen J; Wu D; Yan Z
    Ecotoxicol Environ Saf; 2018 Jun; 154():214-220. PubMed ID: 29476970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals in water, fish and osprey nestlings in Delaware River and Bay.
    Bean TG; Rattner BA; Lazarus RS; Day DD; Burket SR; Brooks BW; Haddad SP; Bowerman WW
    Environ Pollut; 2018 Jan; 232():533-545. PubMed ID: 29032907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.
    Patrolecco L; Capri S; Ademollo N
    Environ Sci Pollut Res Int; 2015 Apr; 22(8):5864-76. PubMed ID: 25352396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.
    Boxall AB; Keller VD; Straub JO; Monteiro SC; Fussell R; Williams RJ
    Environ Int; 2014 Dec; 73():176-85. PubMed ID: 25127044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation of water quality standards for carbamazepine, metoprolol, and metformin and comparison with monitoring data.
    Moermond CT; Smit CE
    Environ Toxicol Chem; 2016 Apr; 35(4):882-8. PubMed ID: 26211655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical pollution of the world's rivers.
    Wilkinson JL; Boxall ABA; Kolpin DW; Leung KMY; Lai RWS; Galbán-Malagón C; Adell AD; Mondon J; Metian M; Marchant RA; Bouzas-Monroy A; Cuni-Sanchez A; Coors A; Carriquiriborde P; Rojo M; Gordon C; Cara M; Moermond M; Luarte T; Petrosyan V; Perikhanyan Y; Mahon CS; McGurk CJ; Hofmann T; Kormoker T; Iniguez V; Guzman-Otazo J; Tavares JL; Gildasio De Figueiredo F; Razzolini MTP; Dougnon V; Gbaguidi G; Traoré O; Blais JM; Kimpe LE; Wong M; Wong D; Ntchantcho R; Pizarro J; Ying GG; Chen CE; Páez M; Martínez-Lara J; Otamonga JP; Poté J; Ifo SA; Wilson P; Echeverría-Sáenz S; Udikovic-Kolic N; Milakovic M; Fatta-Kassinos D; Ioannou-Ttofa L; Belušová V; Vymazal J; Cárdenas-Bustamante M; Kassa BA; Garric J; Chaumot A; Gibba P; Kunchulia I; Seidensticker S; Lyberatos G; Halldórsson HP; Melling M; Shashidhar T; Lamba M; Nastiti A; Supriatin A; Pourang N; Abedini A; Abdullah O; Gharbia SS; Pilla F; Chefetz B; Topaz T; Yao KM; Aubakirova B; Beisenova R; Olaka L; Mulu JK; Chatanga P; Ntuli V; Blama NT; Sherif S; Aris AZ; Looi LJ; Niang M; Traore ST; Oldenkamp R; Ogunbanwo O; Ashfaq M; Iqbal M; Abdeen Z; O'Dea A; Morales-Saldaña JM; Custodio M; de la Cruz H; Navarrete I; Carvalho F; Gogra AB; Koroma BM; Cerkvenik-Flajs V; Gombač M; Thwala M; Choi K; Kang H; Ladu JLC; Rico A; Amerasinghe P; Sobek A; Horlitz G; Zenker AK; King AC; Jiang JJ; Kariuki R; Tumbo M; Tezel U; Onay TT; Lejju JB; Vystavna Y; Vergeles Y; Heinzen H; Pérez-Parada A; Sims DB; Figy M; Good D; Teta C
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35165193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
    Liebig M; Moltmann JF; Knacker T
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
    Maskaoui K; Zhou JL
    Environ Sci Pollut Res Int; 2010 May; 17(4):898-907. PubMed ID: 20024675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and risk assessment of pharmaceuticals in surface waters of the Middle East and North Africa: A review.
    Mheidli N; Malli A; Mansour F; Al-Hindi M
    Sci Total Environ; 2022 Dec; 851(Pt 2):158302. PubMed ID: 36030863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the 2018 drought on pharmaceutical concentrations and general water quality of the Rhine and Meuse rivers.
    Wolff E; van Vliet MTH
    Sci Total Environ; 2021 Jul; 778():146182. PubMed ID: 33714814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Concentrations of Pharmaceuticals in a Nigerian River Catchment.
    Ogunbanwo OM; Kay P; Boxall AB; Wilkinson J; Sinclair CJ; Shabi RA; Fasasi AE; Lewis GA; Amoda OA; Brown LE
    Environ Toxicol Chem; 2022 Mar; 41(3):551-558. PubMed ID: 32955757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecological impact of pharmaceutical pollutants and options of river health improvements - A risk analysis-based approach.
    Singh PK; Ranjan N
    Sci Total Environ; 2024 Jun; 928():172358. PubMed ID: 38614331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geo-referenced simulation of pharmaceuticals in whole watersheds: application of GREAT-ER 4.1 in Germany.
    Lämmchen V; Niebaum G; Berlekamp J; Klasmeier J
    Environ Sci Pollut Res Int; 2021 May; 28(17):21926-21935. PubMed ID: 33411301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of carbamazepine, diclofenac, and their related metabolites and transformation products in a French aquatic environment and preliminary risk assessment.
    Zind H; Mondamert L; Remaury QB; Cleon A; Leitner NKV; Labanowski J
    Water Res; 2021 May; 196():117052. PubMed ID: 33774347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.